A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)

NCT00261508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

DCild Development Disorders, Pervasive
Autistic Disorder
Developmental Disabilities
Asperger Syndrome
Rett Syndrome

Interventions

DRUG: risperidone

Sponsor

Janssen-Ortho Inc., Canada